research Repigmentation of hair following adalimumab therapy
This report describes a patient experiencing hair repigmentation linked to adalimumab therapy, a TNF inhibitor, a phenomenon not previously associated with this class of drugs.





Dubai, United Arab Emirates
Incomplete name
Antalya, Türkiye
Incomplete name
Ampang, Selangor, Malaysia
Newark, NJ, United States
Incomplete name
Florence, Italy